Indian pharma companies have been struggling to maintain margins because of strong headwinds. Due to increased competition, pharma companies are experiencing price erosion in the market, resulting in sluggish growth. While price erosion is not the only issue at hand, China’s lockdown that caused supply chain disruption, the rise in raw material prices, and the Russia-Ukraine war have raised packaging costs.
Mutual fund SIP vs lumpsum investment: What’s the best strategy in this market?
With the stock market experiencing fluctuations, mutual fund investors are unsure whether to opt for SIP or lumpsum investments. Experts suggest that asset allocation should
September 9, 2024